Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

26 Mar 2024

B Sangro, S L Chan, R K Kelley, G Lau, M Kudo, W Sukeepaisarnjaroen, M Yarchoan, E N De Toni, J Furuse, Y K Kang, P R Galle, L Rimassa, A Heurgué, V C Tam, T Van Dao, S C Thungappa, V Breder, Y Ostapenko, M Reig, M Makowsky, M J Paskow, C Gupta, J F Kurland, A Negro, G K Abou-Alfa; HIMALAYA investigators

Annals of Oncology, 2024 Feb 19

Abstract link

Forse può anche interessarti